CGEM – Cullinan Therapeutics Inc
Investors holding1
Combined shares32,176
Combined reported value$494K
CGEM chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Paul Tudor Jones narrow view | 0.00 | Added 42.9% | 32,176 | $494K | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Added 42.9% | 32,176 | 0.00 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 22.3% | 22,518 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | Added 186.2% | 28,988 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | Reduced 65.1% | 10,128 | 0.00 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Added 42.9% | 32,176 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | Added 186.2% | 28,988 | 0.00 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 22.3% | 22,518 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | Reduced 65.1% | 10,128 | 0.00 |
History
1 peakQ3 2026: 1 tracked investors
20212026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Paul Tudor Jones | 32.2K | 22.5K | 29.0K | 10.1K | 29.0K | 22.1K | – | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).